Weekly Psychedelic Links - July 2022

7.1.22

Cannabis

• Fentanyl-laced marijuana is a myth. It’s time to end the hype (Leafly)

• Medical Weed Cards No Longer Required in Virginia Starting July 1 (High Times)

• Hemp, CBD get permanent legal status in NC after 11th-hour rescue (MSN.com)

• Scientists find THC in over 60% of CBD products they tested — and that may be a huge problem (ZME Science)

• UN Report Dramatizes Uptick in Global Cannabis Use (High Times)

• Louisiana Governor Signs Bill Providing Medical Marijuana Workplace Protections For State Employees (Marijuana Moment)

• Maryland Court: Cops Can Stop, Question Someone Who Smells of Pot (High Times)

• Nevada Cannabis Consumption Lounges Could Go Live By End Of 2022 (Marijuana Moment)

• Edibles, beverages infused with cannabis ingredient THC become legal Friday in Minnesota (Star Tribune)

• Inside The Process To Legalize Recreational Cannabis In Germany (Forbes)

• California Bill to Require Cannabis Warnings About Mental Disorder Risks Advances (High Times)

• Pennsylvania Lawmakers Advance Medical Marijuana DUI Protections And Cannabis Banking Reform Bills (Marijuana Moment)

• Texas Supreme Court Bans Smokable Hemp Production, Sales (High Times)

• Montana Lawsuit Challenges Marijuana Ban In State’s Third-Largest City (Marijuana Moment)

• House Panel Approves Amendment to Protect State Legal Cannabis Programs (High Times)

• Feds Fund Development Of Hemp-Based, 3D-Printed Materials To Build Affordable Housing (Marijuana Moment)

• New Vermont Guidance Looks to Eliminate Plastic Waste From State’s Cannabis Industry (High Times)

• Cannabis users are at greater risk for emergency and inpatient care: study (Fox News)

Magic Mushrooms

• These Mormons Have Found a New Faith — in Magic Mushrooms (Rolling Stone)

• New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law (Marijuana Moment)

• Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment (Psychedelic Alpha)

• Digging Up Druggable Targets: Psilocybin Efficacy in a Model of OCD (Psychedelic Science Review)

MDMA

• First-of-its-kind MDMA group therapy trial set to commence (New Atlas)

• Over One Hundred Years of MDMA Research (Drug Science)

Ayahuasca

• How the Shipibo Came to Be the Most Common Group Serving Ayahuasca to Foreigners (DoubleBlind)

Peyote

• Decriminalize Nature Targets Peyote: Drug Reform or Settler Colonialism? (Chacruna)

• Big business could wipe out Mexico’s sacred psychedelic peyote cactus (openDemocracy)

Novel Psychoactive Substances

• How Did A Minnesota Honor Roll Student Die As Her Parents Were Sleeping Upstairs? (Oxygen)

Synthetic Cannabinoids

• A Loophole in Japan’s Weed Laws Is Getting Tens of Thousands High (VICE)

Miscellaneous

• Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot (Marijuana Moment)

• War on drugs prolonged Colombia’s decades-long civil war, landmark report finds (The Guardian)

• Is there a future for psychedelic treatment in Saudi Arabia? (Arab News)

• Do Bad Psychedelic Patents Matter? (Lucid News)

• 4 Recommendations for Disability Inclusion in Psychedelic Therapy Research (Psychiatric Times)

7.8.22

Cannabis

• WNBA Star Brittney Griner Pleads Guilty To Cannabis Charge As Russia Calls Out U.S. Hypocrisy In Maintaining Criminalization (Marijuana Moment)

• Make no mistake, marijuana edibles are legal now in Minnesota (Leafly)

• Washington, D.C. Mayor Signs Medical Cannabis Self-Certification Bill (High Times)

• Pennsylvania Bill Gives Medical Cannabis Patients DUI Protection (High Times)

• Oklahoma: Advocates Turn in Signatures to Place Adult-Use Legalization Measure on November Ballot (NORML)

• Study Shows Flower Still Reigns Supreme in U.S., Canada as Consumer Favorite (High Times)

• Arkansas Activists Set To Turn In Double The Signatures Needed To Put Marijuana Legalization On Ballot (Marijuana Moment)

• Nebraska Medical Marijuana Activists Turn In Ballot Signatures After Campaign Suffers Legal Setback (Marijuana Moment)

• Albania Prompted to Implement Medical Cannabis Reform After U.N. Criticism (High Times)

• U.S. Army Wants To Make Sniper Uniforms Out Of Hemp (Marijuana Moment)

LSD

• A man whose daily headaches felt like an ice pick in his eyes says he tried 12 treatments but only found relief after taking LSD (Insider)

Magic Mushrooms

• New Study Shows Mood, Mental Health Improved by Microdosing Psilocybin (High Times)

• Indiana Nurse Faces Ten Years in Prison for Microdosing Psilocybin Mushrooms (Psychedelic Spotlight)

• Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care (Scientific American)

• Rural Oregon counties are lining up against psilocybin launch (OPB)

MDMA

• Alexandria Ocasio-Cortez Pushes for Psychedelic Reform in Congress (DoubleBlind)

• GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members (Marijuana Moment)

DMT

• Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study (Psychedelic Alpha)

Iboga

• ‘To Heal and to Care for’: Protecting Iboga and Indigenous Voices in the Face of Corporatisation (Volteface)

Novel Psychoactive Substances

• DEA Announces Hearing On Proposed Ban Of Five Psychedelic Compounds Following Significant Pushback (Marijuana Moment)

• Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel Psychedelic Medications for The Treatment of Central Nervous System Disorders (Psychedelic Alpha)

Ketamine

• PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch (Psychedelic Alpha)

Miscellaneous

• The Never-Ending Psychedelic Trip of Michael Pollan (Rolling Stone)

• Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic (Fierce Biotech)

• User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study (Drug Science)

• Tripping the Reward Circuit: Psychedelics for Substance Use Disorders (Psychedelic Science Review)

• Psychedelics Give a Glimpse of Enlightenment (Psychology Today)

7.15.22

Cannabis

• Feds Must Defend Historical Rationale Of Banning Guns For Medical Marijuana Patients, Revised Lawsuit Argues After SCOTUS Ruling (Marijuana Moment)

• ‘Green way of life’: Thailand sees cannabis boom after law change (Al Jazeera)

• Washington DC just legalized weed for all adults—but it’s locals only (Leafly)

• Oklahoma, North Dakota, Arkansas, and Nebraska submit signatures to put cannabis on November ballot (Leafly)

• Study Shows Decrease in Heavy Truck Crash Rates Since Cannabis Legalization (High Times)

• NYPD Will Keep Testing Officers For Marijuana, Reversing Course Hours After Announcing Policy Change Mandated By City (Marijuana Moment)

• Cannabis Laws in France Have Disproportionately Affected Muslims (High Times)

• New York Firefighters Won’t Be Tested For Marijuana, Department Says Following NYPD Leak (Marijuana Moment)

• Argentine Supreme Court Endorses Medical Cannabis Home Grow (High Times)

• Pennsylvania Governor Signs Marijuana Banking And Insurance Reform Bill Into Law (Marijuana Moment)

• Portland Weed Demand Hits Three-Year Low (High Times)

• Pennsylvania Police Arrested Over 13,000 People for Marijuana Possession in 2021 (NORML)

• The Fight for Medical Cannabis in Indonesia (High Times)

• Weed, Like Change, Nourishes The Soil To Regenerate The Cannabis Industry (Forbes)

LSD

• Why David Bowie wasn’t a fan of LSD (Far Out)

Magic Mushrooms

• DEA May Find Itself In Federal Court Again Over Refusal To Provide Psilocybin Access To Terminally Ill Patients (Marijuana Moment)

• Oregon therapeutic psilocybin program sparks some confusion (OPB)

MDMA

• World's first ecstasy 'shop' set to trial in the Netherlands (Mixmag)

• Luxury Champagne Recalled Again Over Ecstacy Contamination (Newsweek)

• MDMA: Rolling from Counterculture to the Clinic Counter (Psychedelic Science Review)

Ayahuasca

• Study suggests ayahuasca users tend to eat healthier, get more exercise, and experience physical and mental health benefits (PsyPost)

Ketamine

• PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders (Psychedelic Alpha)

Miscellaneous

• Ann Shulgin, Forerunner of Today's Psychedelic Re-Emergence, Dies at 91 (Transform Press)

• House Approves Marijuana And Psychedelics Amendments As Part Of Must-Pass Defense Bill (Marijuana Moment)

• What Ethnographers Have Learned from People Who Use Drugs (Undark)

• Inside the Chemistry Lab Where the MDMA Godfather Synthesized Novel Psychedelics (DoubleBlind)

• The Tory Leadership Candidates on Drugs (Volteface)

• Filament Health Issued Third Patent By United States Patent and Trademark Office (Psychedelic Alpha)

• Doctors Urge Access to Psychedelic Therapies in New Mexico (TIME)

• Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So. (Lucid News)

• Villain Or Victim? Understanding The Role of Women In The Latin American Drug Trade (TalkingDrugs)

• San Francisco’s New DA Vows to Ramp Up City’s Drug War (Filter)

• The Battle for Psychedelic Patents (Psychedelic Spotlight)

• How To Become a Psychedelic Therapist (DoubleBlind)

• 5 Countries Where Psychedelics are Legal (Psychedelic Spotlight)

7.22.22

Cannabis

• Senate Leadership Introduces Legislation to End Federal Marijuana Prohibition (NORML)

• District of Columbia: Mayor Signs Legislation Prohibiting Most Employers from Discriminating Against Cannabis Consumers (NORML)

• Legal cannabis is producing more plastic waste than pot (Leafly)

• Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease (Forbes)

• Biden Says He’s ‘Working On’ Bill To Release Cannabis Inmates (High Times)

• Germany, Luxembourg, Malta And The Netherlands Discuss Marijuana Legalization At Historic Joint Meeting (Marijuana Moment)

• Colorado Springs Recreational Cannabis Initiative Qualifies for November Ballot (High Times)

• Minnesota Is Home To America's First Cannabis Disc Golf Course (MIX 108)

• House Passes Bill Permitting Weed Ads on TV and Radio (High Times)

• Colorado's New Lead Marijuana Monitor Treks Through Heavy Issues (Westword)

• Cannabis Telemedicine Launches in Montana (High Times)

• Montana Marijuana Businesses Face Seemingly Endless Cycle Of Local Votes On Allowing Them To Operate (Marijuana Moment)

• People Busted for Weed in the U.K. Could Lose Passports Under Proposed Rules (High Times)

• Missouri Marijuana Legalization Measure In Danger Of Not Qualifying For Ballot (Marijuana Moment)

• Denver officials want to save struggling cannabis delivery businesses (The Denver Post)

• Study Finds Australians Support Cannabis Use Over Smoking Tobacco (High Times)

• House Will Not Vote On Marijuana Amendments For Veterans And Public Housing Residents After Committee Snag (Marijuana Moment)

• Marijuana use is higher among US states that have legalized recreational cannabis use (News-Medical)

LSD

• The Doors of Expression: LSD Alters Epigenetics and Protein Induction (Psychedelic Science Review)

• Science Feature: MindMed’s LSD Trial for ADHD (Microdose)

• Watch John Lennon explain that 'Lucy in the Sky with Diamonds' was not about LSD (Far Out)

Magic Mushrooms

• The Sloppy Science of Psilocybin Microdosing Surveys (Psychedelic Spotlight)

• A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies (PsyPost)

• Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up (Scientific American)

MDMA

• Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review (CBC)

• 'Corrective' measures ordered, but Health Canada says 2nd MDMA trial can continue (CBC)

DMT

• Teenager Used LSD And DMT To Help Overcome Trauma, Case Report Says (IFLScience)

Ayahuasca

• Churches sue to use hallucinogenic tea in religious practice (UPI)

• The Global Ayahuasca Boom: What About the Conservation of the Ayahuasca Vine? (Chacruna)

5-MeO-DMT

• The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Novel Psychoactive Substances

• Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs (Psychedelic Alpha)

Synthetic Cannabinoids

• Weed vapes probably sending a toxic gas to your lungs, study finds (Salon)

• Cannabis getting stronger with synthetic versions added leading to psychosis, report warns (Independent.ie)

Ketamine

• Largest-ever clinical study of ketamine therapy shows that at-home model can be a safe, effective treatment for anxiety and depression; 62% fewer patients report suicidal ideation after four sessions (PR Newswire)

• Ketamine Beneficial For Treating Neonatal, And Pediatric Epilepsy: Study (Medical Dialogues)

Miscellaneous

• The Long, Strange Relationship Between Psychedelics and Telepathy (VICE)

• DEA Sued Over ‘Unlawful’ Delays On Psychedelic And Marijuana Public Records Requests Through FOIA (Marijuana Moment)

• Colorado Psychedelics Legalization Measure Qualifies for November Ballot (DoubleBlind)

• Keeping the Hippie Dream Alive (The New York Times)

• Accessibility Is Key for the Psychedelic Revolution (Pharmacy Times)

• Podcast aims to raise awareness about future of psychedelic treatments (CBC)

• Skip the trip – does the world need non-hallucinogenic psychedelics? (leafie)

• New Regulations for Psychedelics? Here's What Investors Need to Know (The Motley Fool)

7.29.22

Cannabis

• Weedmaps again advertising illegal marijuana retailers and products, complaints allege (Marijuana Business Daily)

• Singapore Executes Man for Cannabis Trafficking (High Times)

• House Passes Bipartisan Marijuana Research Bill, With Senate Expected To Send It To President Soon (Marijuana Moment)

• Zimbabwe OKs First Medicinal Cannabis Sales (High Times)

• Secret Australian marijuana facility exposes location after turning sky pink (The Washington Post)

• Biden Administration Proposes Prisoner Swap To Free Brittney Griner (High Times)

• Over 850 Doctors in Thailand Protest Pot Legalization (High Times)

• Senator Files Bill To Allow Marijuana Advertising On TV And Radio In Legal States (Marijuana Moment)

• The 'World's Biggest Cannabis Scam' Is Totally Unravelling (VICE)

• Bronx Cannabis Hub Fosters Opportunity in Communities Hit Hard by Arrests (Filter)

• Cannabis Users Less Likely to Face Complications After Spinal Fusion Surgery (High Times)

• 15 State Attorneys General File Brief Opposing Lawsuit To Help Put Medical Marijuana On Nebraska Ballot (Marijuana Moment)

• Thai businesses cash in on cannabis, from milk tea to toothpaste (Reuters)

• Missouri Marijuana Legalization Initiative Short Of Signatures Needed For Ballot In County Reviews (Marijuana Moment)

• New Hampshire stands alone in New England as only state without legal marijuana (WMUR)

LSD

• New Zealand Government Grants $650K For LSD Microdosing Trials (Benzinga)

• Operation Julie: Rural Wales LSD bust becomes a musical (BBC)

Magic Mushrooms

• DEA Sued Again Over Refusal To Allow Psilocybin Access For Patients Despite Federal Law (Marijuana Moment)

• Why some of Colorado’s foremost shrooms advocates won’t be voting to legalize psilocybin (The Denver Post)

• Legal psilocybin prescriptions in Canada (Drug Science)

• Project Solace: The World’s Largest Medical Psilocybin Access and Data Project (Psychedelic Spotlight)

• COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa (Psychedelic Alpha)

DMT

• U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation (Psychedelic Alpha)

Novel Psychoactive Substances

• DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits (Marijuana Moment)

• Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals (STAT News)

• Festival drugs: Warning over 'imposter' substances threat (BBC)

• Ecstasy for the 21st Century: Designer Drugs to Improve MDMA Therapy (Psychedelic Science Review)

Synthetic Cannabinoids

• Easy On The Eyes — This Company Reports Using a Unique Synthetic Cannabinoid Derivative To Treat Glaucoma (Benzinga)

Nitrous Oxide

• Doctors warn ‘dangerous’ laughing gas is becoming an ‘epidemic’ amid rise in hospitalisations (The Independent)

• A Law will Prohibit the Sale of Nitrous Oxide or “Laughing Gas” to Minors in Bulgaria (Novinite.com)

Ketamine

• At Home Sublingual Ketamine Exhibits Rapid And Significant Antidepressant And Anxiolytic Effects (Medical Dialogues)

• Ketamine found to be unlikely to lead to addiction (Medical Xpress)

• Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine (Psychedelic Alpha)

Miscellaneous

• Biden Administration Plans For Legal Psychedelic Therapies Within Two Years (The Intercept)

• San Francisco Launches Bid to Decriminalize Psychedelics (Filter)

• Your Genes May Determine How You React To Psychedelic Drugs (IFLScience)

• The Psychoactive Substances Act on Trial (Volteface)

• The High-Stakes Race to Engineer New Psychedelic Drugs (WIRED)

• Trump Urges ‘Very Quick Trial’ and Death Penalty for Drug Dealers (High Times)

• The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream (Bloomberg)

• One in four Americans say they’ve tried at least one psychedelic drug (YouGov)

• Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’ (The Sydney Morning Herald)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.29.21

Cannabis

• With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)

• Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)

• Why did Texas ban Delta-8? (Popular Science)

• Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)

• California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)

• State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)

• The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)

• Cannabis is one industry that's actually coming out of Covid even stronger (CNN)

• South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

• New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)

• Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)

• Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)

• Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)

• Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)

• Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)

LSD

• Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)

Magic Mushrooms

• Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)

• Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)

• Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)

• Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)

• More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)

• MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

• Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)

MDMA

• No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)

• MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)

Ayahuasca

• Des Moines church fights IRS over ‘religious’ use of hallucinogenic drug (Iowa Capital Dispatch)

5-MeO-DMT

• Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)

Novel Psychoactive Substances

• Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)

• Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)

• Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)

• Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)

Synthetic Cannabinoids

• The Dangers of 'Spice' and Other Synthetic Cannabinoids (Discover Magazine)

Ketamine

• European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)

• Cocaine, ketamine use on the rise: survey (PerthNow)

• Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)

• MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)

Miscellaneous

• Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)

• Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)

• Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)

• Addressing Abuse in Psychedelic Spaces (Psychedelics Today)

• North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)

• Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)

• Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)

• How Gender Affects the Way We Use Drugs (TalkingDrugs)

• DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)

• MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)

• Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)

• Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)

• Psychedelic Research Beyond Depression & Trauma (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.23.21

Cannabis

• Schumer Celebrates 4/20 Marijuana Holiday On Senate Floor (Marijuana Moment)

• US House Passes Bill To Normalize Adult-Use Cannabis Commerce (NORML)

• Virginia Governor Signs Marijuana Legalization Bill In Ceremonial Event—Even Though It’s Already Enacted (Marijuana Moment)

• New Jersey Supreme Court Rules Company Must Cover Employee's Medical Marijuana Costs (MERRY JANE)

• Nine In Ten Americans Support Legalizing Marijuana For Recreational Or Medical Use, New Pew Poll Finds (Marijuana Moment)

• Florida Supreme Court Kills 2022 Marijuana Legalization Initiative That Hundreds Of Thousands Had Signed (Marijuana Moment)

• Border weed: How the hometown of tater tots became a cannabis capital (Politico)

• Louisiana Lawmakers Approve Bill To Legalize Medical Marijuana Flower For Patients (Marijuana Moment)

• Veterans Medical Marijuana Safe Harbor Act Reintroduced (NORML)

• Minnesota Marijuana Legalization Bill Clears Eighth Committee On Route To The House Floor (Marijuana Moment)

• Two-thirds of La. voters support legalizing marijuana; state lawmakers on both sides of the aisle eye legalization (WAFB)

LSD

• Today Is Bicycle Day, Which Isn’t Quite What You Think (Mother Jones)

• LSD Side-Effects: Risks To Be Aware of When Consuming LSD (The Third Wave)

Magic Mushrooms

• Oregon’s and Compass’s Opposite Approaches to Psilocybin Therapy Should Coexist, Says Initiator of Measure 109 (Chacruna)

• Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application (Psilocybin Alpha)

MDMA

• MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration (The Canberra Times)

• This is why sex on MDMA feels so good, according to experts (Gentside UK)

Ayahuasca

• Advocacy Group Aims to Decriminalize Ayahuasca in Portland (Willamette Week)

• Some Vermonters Turn to Ayahuasca as a 'Last Resort' to Heal Their Bodies and Minds (Seven Days)

5-MeO-DMT

• Researchers In Europe, U.S. Team Up To Produce First Ever 5-MeO-DMT Psychedelic Training Program (Forbes)

• Toad Conservation (Chacruna)

Peyote

• Hello, Religious Privilege is Good and Here's Why (Patheos)

Novel Psychoactive Substances

• 18-MC Has Unique Brain Functions and Mechanisms (Psychedelic Science Review)

Synthetic Cannabinoids

• Study explores synthetic cannabinoid for cancer-related anorexia (Outsourcing-Pharma.com)

Ketamine

• PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

• Ketamine Infusion: How Ketamine Can Treat Depression, Anxiety, PTSD, and More (DoubleBlind)

PCP

• State's medical expert to grand jury: 'Police didn't kill Daniel Prude' (WXXI News)

Miscellaneous

• Norway opposition torpedoes plan to decriminalise drug use (France 24)

• Washington State Lawmakers Downgrade Proposed Drug Possession Penalties Ahead Of House Floor Vote (Marijuana Moment)

• Biden Is Allegedly Planning to Double Down on Trump's Prohibitionist Drug Policies (MERRY JANE)

• MindMed To Commence Trading on Nasdaq (Psilocybin Alpha)

• The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for an Accessible Future (Psychedelics Today)

• Jewish psychedelics movement blasts off with first-ever conference (The Times of Israel)

• ATAI Nasdaq IPO Plans Announced (Truffle Report)

• Researchers Slam Drug War At Federally Hosted Psychedelics Event (Marijuana Moment)

• There’s a Land Grab for Psychedelic Patents: Here’s What We Can Do About It (Psychedelic Times)

• You're Not Hallucinating: Black People Are Being Left Out of the Psychedelic Renaissance (The Root)

• People who regularly use psychoactive substances experienced negative impacts during COVID-19 (News-Medical.net)

• Most Canadians not ready to expand drug legalization beyond cannabis: poll (Coast Reporter)

• Extinction Rebellion founder says psychedelic drugs 'helped start environmental movement' (Wales Online)

• Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica (Psilocybin Alpha)

• Psychedelic Experience launches new website to help navigate the world of psychedelics (PR Newswire)

• The Overlap Between Kink/BDSM and Psychedelics (Chacruna)

• Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction (Psilocybin Alpha)

• Michael Pollan: A Catalyst to the Psychedelic Renaissance (The Third Wave)

• If You're Going to Solo Trip On Psychedelics, Bear This in Mind (VICE)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.16.21

Cannabis

• New Mexico Legalizes Adult-Use Cannabis (Forbes)

• 69 Percent Of Americans Now Support Legalizing Marijuana—An All-Time High, Quinnipiac Poll Finds (Marijuana Moment)

• Marijuana legalization has won (Vox)

• Four More States Could Still Legalize Marijuana This Year After New Mexico, New York And Virginia (Marijuana Moment)

• Nevada Lawmakers Approve Marijuana Bill To Allow On-Site Consumption Lounges (Marijuana Moment)

• Alabama Medical Marijuana Legalization Bill That Already Passed The Senate Heads To House Floor (Marijuana Moment)

• Women Paved the Way for Mexico’s Cannabis Legalization Movement, and Here’s How They Did It (MERRY JANE)

• Limited Tennessee Medical Marijuana Bill Heads To Senate Floor (Marijuana Moment)

• Sixth Minnesota House Committee Approves Marijuana Legalization Bill On Its Path To The Floor (Marijuana Moment)

• Texas Lawmakers Approve Marijuana Decriminalization Bill In Committee (Marijuana Moment)

• With Virginia moving forward, state Democratic leaders want NC to be next to legalize marijuana (Fox 8)

Magic Mushrooms

• Psilocybin Therapy May Work as Well as Common Antidepressant (Scientific American)

• Denver pursues further decriminalization of magic mushrooms (Axios)

• Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits (Neuroscience News)

• Psilocybin Mushrooms Greatly Enhance Creative Thinking, New Clinical Study Confirms (MERRY JANE)

• Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brasil (Psilocybin Alpha)

• Wood Lover’s Paralysis: Psilocybin’s Rare Sickness (Truffle Report)

5-MeO-DMT

• The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Mescaline

• Keepers of the Matrix: A Beginner’s Guide to Understanding Sacred Cacti (DoubleBlind)

Peyote

• Peyote Conservation Group Asks to Include Cultivation in California Decrim Bill (Truffle Report)

Synthetic Cannabinoids

• Why Synthetic Cannabinoids Can Be a Good Thing (Green Entrepreneur)

Miscellaneous

• Psychedelics In Groups? First Study Of Its Kind Shows Potential For Collective Settings (Forbes)

• California Bill To Legalize Possession Of Psychedelics Clears Second Senate Committee (Marijuana Moment)

• Drug-testing to be made permanent at music festivals (Newshub)

• Oregon Legislature Adds Changes to Drug Decriminalization Law (Truffle Report)

• COVID-19 and Psychedelic Group Work: It’s Still Too Soon (Psychedelics Today)

• Washington State’s Drug Policies: Weighing Methods to Decriminalize Possession (Truffle Report)

• Plant Medicine Coalition Launches Grants For Community Healing Hubs in D.C. (Truffle Report)

• Ex Gov. Perry Backs Texas Psychedelics Study Bill (Truffle Report)

• UCSF Launches Translational Psychedelic Research (TrPR) Program (Lucid News)

• YouTube Loosens Restrictions, Expands Monetization for Drug Content (Truffle Report)

• Fireside Project: The 21st Century’s First Psychedelic Peer Support Hotline (Lucid News)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.